Literature DB >> 18663502

Population structure of invasive Streptococcus pneumoniae isolates in Italy prior to the implementation of the 7-valent conjugate vaccine (1999-2003).

G Gherardi1, F D'Ambrosio, M Monaco, R Camilli, L De Florio, F D'Ancona, G Dicuonzo, A Pantosti.   

Abstract

A total of 773 pneumococcal isolates were collected from a nationwide surveillance of invasive pneumococcal diseases during 1999-2003 prior to the implementation of the 7-valent conjugate vaccine (PCV7) in Italy. The isolates included vaccine serotypes (VS, 393 isolates), vaccine-related serotypes (VRS, 93), and nonvaccine serotypes (NVS, 279). The ten most prevalent serotypes were: 14 (16.4%), 3 (8.4%), 23F (8%), 19F (7.4%), 4 (5.9%), 7F (5.8%), 9V (5.3%), 6B (4.9%), 19A (4.7%), and 1 (3.7%). VRS or NVS isolates showed a lower rate of penicillin or drug resistance than VS. Representative isolates of the major VS, VRS, and NVS were genotyped by pulsed field gel electrophoresis (PFGE) and multilocus sequence typing (MLST). The isolates examined were found to belong to 18 international clones and to eight newly described clones. VS isolates sharing clonal groups with VRS or NVS were also detected. Evidence of a past history of capsular switching events was observed in five clones.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18663502     DOI: 10.1007/s10096-008-0581-8

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  15 in total

1.  Zinc metalloproteinase genes in clinical isolates of Streptococcus pneumoniae: association of the full array with a clonal cluster comprising serotypes 8 and 11A.

Authors:  Romina Camilli; Elena Pettini; Maria Del Grosso; Gianni Pozzi; Annalisa Pantosti; Marco R Oggioni
Journal:  Microbiology (Reading)       Date:  2006-02       Impact factor: 2.777

Review 2.  The pneumococcal problem.

Authors:  S K Obaro; M A Monteil; D C Henderson
Journal:  BMJ       Date:  1996-06-15

3.  Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I.

Authors:  W P Hausdorff; J Bryant; P R Paradiso; G R Siber
Journal:  Clin Infect Dis       Date:  2000-01       Impact factor: 9.079

4.  Clonal and capsular types decide whether pneumococci will act as a primary or opportunistic pathogen.

Authors:  K Sjöström; C Spindler; A Ortqvist; M Kalin; A Sandgren; S Kühlmann-Berenzon; B Henriques-Normark
Journal:  Clin Infect Dis       Date:  2006-01-17       Impact factor: 9.079

5.  Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae.

Authors:  Moe H Kyaw; Ruth Lynfield; William Schaffner; Allen S Craig; James Hadler; Arthur Reingold; Ann R Thomas; Lee H Harrison; Nancy M Bennett; Monica M Farley; Richard R Facklam; James H Jorgensen; John Besser; Elizabeth R Zell; Anne Schuchat; Cynthia G Whitney
Journal:  N Engl J Med       Date:  2006-04-06       Impact factor: 91.245

6.  Antibiotic-resistant invasive pneumococcal clones in Italy.

Authors:  Giovanni Gherardi; Loredana Fallico; Maria Del Grosso; Federica Bonanni; Fabio D'Ambrosio; Riccardo Manganelli; Giorgio Palù; Giordano Dicuonzo; Annalisa Pantosti
Journal:  J Clin Microbiol       Date:  2006-11-22       Impact factor: 5.948

7.  Effectiveness of the 7-valent pneumococcal conjugate vaccine: a population-based case-control study.

Authors:  Aurelio Barricarte; Jesús Castilla; Alberto Gil-Setas; Luis Torroba; José Antonio Navarro-Alonso; Fátima Irisarri; Maite Arriazu
Journal:  Clin Infect Dis       Date:  2007-04-16       Impact factor: 9.079

8.  Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine.

Authors:  Cynthia G Whitney; Monica M Farley; James Hadler; Lee H Harrison; Nancy M Bennett; Ruth Lynfield; Arthur Reingold; Paul R Cieslak; Tamara Pilishvili; Delois Jackson; Richard R Facklam; James H Jorgensen; Anne Schuchat
Journal:  N Engl J Med       Date:  2003-05-01       Impact factor: 91.245

9.  Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004.

Authors:  Lauri A Hicks; Lee H Harrison; Brendan Flannery; James L Hadler; William Schaffner; Allen S Craig; Delois Jackson; Ann Thomas; Bernard Beall; Ruth Lynfield; Arthur Reingold; Monica M Farley; Cynthia G Whitney
Journal:  J Infect Dis       Date:  2007-10-04       Impact factor: 5.226

10.  Genotypes of invasive pneumococcal isolates recently recovered from Italian patients.

Authors:  Giordano Dicuonzo; Giovanni Gherardi; Robert E Gertz; Fabio D'Ambrosio; Antonio Goglio; Giulia Lorino; Simona Recchia; Annalisa Pantosti; Bernard Beall
Journal:  J Clin Microbiol       Date:  2002-10       Impact factor: 5.948

View more
  1 in total

1.  Serotype and clonal evolution of penicillin-nonsusceptible invasive Streptococcus pneumoniae in the 7-valent pneumococcal conjugate vaccine era in Italy.

Authors:  Giovanni Gherardi; Fabio D'Ambrosio; Daniela Visaggio; Giordano Dicuonzo; Maria Del Grosso; Annalisa Pantosti
Journal:  Antimicrob Agents Chemother       Date:  2012-07-02       Impact factor: 5.191

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.